• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统相互作用网络筛选确定CRMP1是亨廷顿蛋白错误折叠和神经毒性的新型抑制因子。

Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity.

作者信息

Stroedicke Martin, Bounab Yacine, Strempel Nadine, Klockmeier Konrad, Yigit Sargon, Friedrich Ralf P, Chaurasia Gautam, Li Shuang, Hesse Franziska, Riechers Sean-Patrick, Russ Jenny, Nicoletti Cecilia, Boeddrich Annett, Wiglenda Thomas, Haenig Christian, Schnoegl Sigrid, Fournier David, Graham Rona K, Hayden Michael R, Sigrist Stephan, Bates Gillian P, Priller Josef, Andrade-Navarro Miguel A, Futschik Matthias E, Wanker Erich E

机构信息

Max Delbrueck Center for Molecular Medicine, 13125 Berlin, Germany;

Institute of Theoretical Biology, Humboldt University of Berlin, 10115 Berlin, Germany;

出版信息

Genome Res. 2015 May;25(5):701-13. doi: 10.1101/gr.182444.114.

DOI:10.1101/gr.182444.114
PMID:25908449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4417118/
Abstract

Assemblies of huntingtin (HTT) fragments with expanded polyglutamine (polyQ) tracts are a pathological hallmark of Huntington's disease (HD). The molecular mechanisms by which these structures are formed and cause neuronal dysfunction and toxicity are poorly understood. Here, we utilized available gene expression data sets of selected brain regions of HD patients and controls for systematic interaction network filtering in order to predict disease-relevant, brain region-specific HTT interaction partners. Starting from a large protein-protein interaction (PPI) data set, a step-by-step computational filtering strategy facilitated the generation of a focused PPI network that directly or indirectly connects 13 proteins potentially dysregulated in HD with the disease protein HTT. This network enabled the discovery of the neuron-specific protein CRMP1 that targets aggregation-prone, N-terminal HTT fragments and suppresses their spontaneous self-assembly into proteotoxic structures in various models of HD. Experimental validation indicates that our network filtering procedure provides a simple but powerful strategy to identify disease-relevant proteins that influence misfolding and aggregation of polyQ disease proteins.

摘要

具有扩展的聚谷氨酰胺(polyQ) tracts的亨廷顿蛋白(HTT)片段聚集体是亨廷顿舞蹈症(HD)的病理标志。这些结构形成并导致神经元功能障碍和毒性的分子机制尚不清楚。在这里,我们利用HD患者和对照者选定脑区的可用基因表达数据集进行系统的相互作用网络筛选,以预测与疾病相关的、脑区特异性的HTT相互作用伙伴。从一个大的蛋白质-蛋白质相互作用(PPI)数据集开始,逐步的计算筛选策略有助于生成一个聚焦的PPI网络,该网络直接或间接将HD中可能失调的13种蛋白质与疾病蛋白HTT连接起来。该网络使得发现了神经元特异性蛋白CRMP1,它靶向易于聚集的N端HTT片段,并在各种HD模型中抑制它们自发自组装成蛋白毒性结构。实验验证表明,我们的网络筛选程序提供了一种简单但强大的策略,以识别影响多聚谷氨酰胺疾病蛋白错误折叠和聚集的与疾病相关的蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/67b2daedfe60/701f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/147013d8d310/701f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/c4c7a5f0fb38/701f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/6af1e723abe7/701f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/1409132c9d27/701f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/071887c9685e/701f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/67b2daedfe60/701f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/147013d8d310/701f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/c4c7a5f0fb38/701f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/6af1e723abe7/701f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/1409132c9d27/701f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/071887c9685e/701f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e44/4417118/67b2daedfe60/701f06.jpg

相似文献

1
Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity.系统相互作用网络筛选确定CRMP1是亨廷顿蛋白错误折叠和神经毒性的新型抑制因子。
Genome Res. 2015 May;25(5):701-13. doi: 10.1101/gr.182444.114.
2
The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.亨廷顿蛋白前17个氨基酸在亨廷顿舞蹈病中的新作用。
Biomol Concepts. 2015 Mar;6(1):33-46. doi: 10.1515/bmc-2015-0001.
3
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.致病性亨廷顿蛋白外显子1自发自组装成淀粉样结构。
Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167.
4
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.绿茶(-)-表没食子儿茶素-3-没食子酸酯调节亨廷顿蛋白错误折叠的早期事件并降低亨廷顿舞蹈病模型中的毒性。
Hum Mol Genet. 2006 Sep 15;15(18):2743-51. doi: 10.1093/hmg/ddl210. Epub 2006 Aug 7.
5
14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.14-3-3ζ蛋白对于多聚谷氨酰胺扩展的亨廷顿蛋白的聚集体形成是不可或缺的。
Neurosci Lett. 2008 Jan 24;431(1):45-50. doi: 10.1016/j.neulet.2007.11.018. Epub 2007 Nov 17.
6
Cholesterol Modifies Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.胆固醇修饰亨廷顿蛋白与脂质膜的结合、对脂质膜的破坏以及在脂质膜上的聚集。
Biochemistry. 2016 Jan 12;55(1):92-102. doi: 10.1021/acs.biochem.5b00900. Epub 2015 Dec 22.
7
Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.亨廷顿蛋白外显子1原纤维静态和动态结构域的固态核磁共振研究
Biochemistry. 2015 Jun 30;54(25):3942-9. doi: 10.1021/acs.biochem.5b00281. Epub 2015 Jun 16.
8
Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.亨廷顿蛋白与伴侣的亲和力不会因多聚谷氨酰胺长度的改变而改变:聚集本身会引发异常相互作用。
Hum Mol Genet. 2011 Jul 15;20(14):2795-806. doi: 10.1093/hmg/ddr178. Epub 2011 Apr 25.
9
Aggregation in Huntington's disease: insights through modelling.亨廷顿舞蹈症中的聚集现象:通过建模获得的见解
Genome Inform. 2005;16(1):262-71.
10
Discovery of a novel aggregation domain in the huntingtin protein: implications for the mechanisms of Htt aggregation and toxicity.发现亨廷顿蛋白中的一个新聚集结构域:对 Htt 聚集和毒性机制的影响。
Angew Chem Int Ed Engl. 2013 Jan 7;52(2):562-7. doi: 10.1002/anie.201206561. Epub 2012 Nov 12.

引用本文的文献

1
Co-Aggregation and Parallel Aggregation of Specific Proteins in Major Mental Illness.特定蛋白质在重大精神疾病中的共聚集和并行聚集。
Cells. 2023 Jul 13;12(14):1848. doi: 10.3390/cells12141848.
2
On the identification of potential novel therapeutic targets for spinocerebellar ataxia type 1 (SCA1) neurodegenerative disease using EvoPPI3.利用 EvoPPI3 鉴定脊髓小脑共济失调 1 型(SCA1)神经退行性疾病的潜在新型治疗靶点
J Integr Bioinform. 2023 Feb 28;20(2). doi: 10.1515/jib-2022-0056. eCollection 2023 Jun 1.
3
Integrative Proteome Analysis Revels 3-Hydroxybutyrate Exerts Neuroprotective Effect by Influencing Chromatin Bivalency.

本文引用的文献

1
Proteostasis impairment in protein-misfolding and -aggregation diseases.蛋白质错误折叠和聚集疾病中的蛋白质稳态失调。
Trends Cell Biol. 2014 Sep;24(9):506-14. doi: 10.1016/j.tcb.2014.05.003. Epub 2014 Jun 16.
2
Super Spy variants implicate flexibility in chaperone action.超级间谍变体暗示了伴侣蛋白作用的灵活性。
Elife. 2014;3:e01584. doi: 10.7554/eLife.01584. Epub 2014 Feb 4.
3
Cognitive decline in prodromal Huntington Disease: implications for clinical trials.前驱期亨廷顿病的认知能力下降:对临床试验的影响。
整合蛋白质组学分析揭示 3-羟基丁酸通过影响染色质二价性发挥神经保护作用。
Int J Mol Sci. 2023 Jan 3;24(1):868. doi: 10.3390/ijms24010868.
4
Phosphorylated CRMP1, axon guidance protein, is a component of spheroids and is involved in axonal pathology in amyotrophic lateral sclerosis.磷酸化的CRMP1(轴突导向蛋白)是球体的一个组成部分,并参与肌萎缩侧索硬化症的轴突病理过程。
Front Neurol. 2022 Sep 27;13:994676. doi: 10.3389/fneur.2022.994676. eCollection 2022.
5
Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.亨廷顿病神经退行性变中多个细胞通路的失调涉及突变亨廷顿蛋白相互作用图谱。
J Huntingtons Dis. 2022;11(3):243-267. doi: 10.3233/JHD-220538.
6
Inhibition of Crmp1 Phosphorylation at Ser522 Ameliorates Motor Function and Neuronal Pathology in Amyotrophic Lateral Sclerosis Model Mice.抑制 Crmp1 在丝氨酸 522 位的磷酸化可改善肌萎缩侧索硬化症模型小鼠的运动功能和神经元病理。
eNeuro. 2022 May 23;9(3). doi: 10.1523/ENEURO.0133-22.2022. Print 2022 May-Jun.
7
Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets.多聚谷氨酰胺(PolyQ)疾病中的修饰途径:从遗传筛选到药物靶点。
Cell Mol Life Sci. 2022 May 3;79(5):274. doi: 10.1007/s00018-022-04280-8.
8
Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity.淀粉样聚集蛋白通过获得功能毒性导致神经元溶酶体缺陷。
Life Sci Alliance. 2021 Dec 21;5(3). doi: 10.26508/lsa.202101185. Print 2022 Mar.
9
Advances in Proteomics Allow Insights Into Neuronal Proteomes.蛋白质组学的进展有助于深入了解神经元蛋白质组。
Front Mol Neurosci. 2021 Apr 15;14:647451. doi: 10.3389/fnmol.2021.647451. eCollection 2021.
10
Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease.亨廷顿病症状进展时脑脊液中脑啡肽原减少。
Mov Disord. 2021 Feb;36(2):481-491. doi: 10.1002/mds.28391. Epub 2020 Nov 28.
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1233-9. doi: 10.1136/jnnp-2013-305114. Epub 2013 Aug 2.
4
Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database.亨廷顿病及其治疗靶点基因:基于 HD Research Crossroads 数据库的全球功能谱。
BMC Neurol. 2012 Jun 28;12:47. doi: 10.1186/1471-2377-12-47.
5
Identifying polyglutamine protein species in situ that best predict neurodegeneration.在原位鉴定最能预测神经退行性变的多聚谷氨酰胺蛋白种类。
Nat Chem Biol. 2011 Oct 30;7(12):925-34. doi: 10.1038/nchembio.694.
6
Ranking candidate disease genes from gene expression and protein interaction: a Katz-centrality based approach.基于 Katz 中心度的基因表达和蛋白质互作数据对候选疾病基因进行排序。
PLoS One. 2011;6(9):e24306. doi: 10.1371/journal.pone.0024306. Epub 2011 Sep 2.
7
Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative.亨廷顿病 CAG 突变在纹状体和小脑中的差异效应是定量的,而不是定性的。
Hum Mol Genet. 2011 Nov 1;20(21):4258-67. doi: 10.1093/hmg/ddr355. Epub 2011 Aug 12.
8
Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease.染色质结构的改变是亨廷顿病小鼠模型中热休克反应进行性损伤的基础。
J Clin Invest. 2011 Aug;121(8):3306-19. doi: 10.1172/JCI57413. Epub 2011 Jul 25.
9
ConTra v2: a tool to identify transcription factor binding sites across species, update 2011.ConTra v2:一种跨物种识别转录因子结合位点的工具,更新于 2011 年。
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W74-8. doi: 10.1093/nar/gkr355. Epub 2011 May 16.
10
Neurotoxic protein oligomerisation associated with polyglutamine diseases.神经毒性蛋白寡聚化与多聚谷氨酰胺疾病有关。
Acta Neuropathol. 2010 Oct;120(4):419-37. doi: 10.1007/s00401-010-0703-0. Epub 2010 Jun 1.